AHMEDABAD, 4 FEBRUARY: અગ્રણી બ્રોકરેજ હાઉસ તથા ફંડ હાઉસ તરફથી પસંદગીના સ્ટોક્સમાં ખરીદી\ વેચાણ\ હોલ્ડ કરવા માટે ભલામણ કરવામાં આવી છે. તે રોકાણકારોના અભ્યાસ માટે અત્રે રજૂ કરીએ છીએ.

CLSA on VBL: Upgrade to Buy on Company, cut target price at Rs 770/Sh (Positive)

Investecon Syrma SGS: Upgrade to Hold on Company, target price at Rs 460/Sh (Positive)

Investecon MGL: Upgrade to Buy on Company, target price at Rs 1600/Sh (Positive)

Equirus on Lupin: Upgrade to Buy on Company, target price at Rs 2379/Sh (Positive)

MOSL on Lemon Tree: Maintain Buy on Company, target price at Rs 190/Sh (Positive)

MOSL on Indian Hotels: Maintain Buy on Company, target price at Rs 960/Sh (Positive)

Elara on Auto Pharma: Maintain Buy on Company, target price at Rs 1568/Sh (Positive)

Jefferieson AWL: Initiate Buy on Company, target price at Rs 370/Sh (Positive)

Jefferieson Pharma Sector: Indian firms increase selling of gRevlimid vs previous quarter. Zydus entersgVascepa market, gains 1% market share to begin with Lupin continue to gain market share in Mirabegron (Positive)

JefferiesOn India Semiconductors: $18bn of investments underway in a chip fab and 4  OSAT/ATMP projects. India has strong potential to replicate success in auto tosemi-conductor (Positive)

JP Morgan on Paints: Recent dealer checks suggest marginal improvement in demand trends so far in Jan-Feb’25. Remainconstructive on Pidilite (Neutral)

Investec on Kaynes: Upgrade to Hold on Company, targetprice at Rs 3465/Sh (Neutral)

Macquarie on Titan: Maintain Outperform on Company, cut target price at Rs 4000/Sh (Neutral)

Macquarie on Info Edge: Maintain Underperform on Company, raise targetprice at Rs 5200/Sh (Neutral)

MS on Can Fin Homes: Maintain Overweight on Company, target price at Rs 885/Sh (Neutral)

Nuvama on Balkrishna: Maintain Buy on Company, cut target price at Rs 3100/Sh(Neutral)

(Disclaimer: The information provided here is investment advice only. Investing in the markets is subject to risks and please consult your advisor before investing.)

(સ્પષ્ટતા: અત્રેથી આપવામાં આવતી તમામ પ્રકારની માહિતી કોઇપણ પ્રકારે રોકાણ/ ટ્રેડીંગ માટેની સલાહ નથી. બજારોમાં રોકાણ જોખમોને આધીન છે અને રોકાણ કરતા પહેલા કૃપા કરીને તમારા સલાહકારની સલાહ લો.)